BeautyWith NoBoundary

Zentite reached #1 in mainland China through clinical validation and academic credibility.
Now going global.

Scroll ↓
6,000+
Installations
800K
Treatments / Year
#1
China Market

The goal now is to take it global.
Start with the science, let clinical results drive commercial traction.
That's the only way to build something that lasts.

— Nero Zhang, Head of APAC
Nero
Zhang
Head of APAC
Boston Aesthetics INC.

Before Boston Aesthetics, three years at Fotona leading five authorized distributor teams across Shanghai — 100+ device installations, 450 clinic partnerships.

I learned what separates a distributor who moves product from one who builds a market. I joined Boston Aesthetics because the product reached #1 through an academic-first approach. The model works.

加入 Boston Aesthetics 之前,我在 Fotona 负责上海市场三年——管理 5 个公立代理商团队,完成超过 100 台装机,深入对接 450 家医疗机构。

Zentite

Golden microneedle is a crowded category. Zentite took a different path — letting clinical outcomes drive adoption, building momentum through academic credibility instead of marketing spend.

S

Smooth

Advanced vibration control

T

Targeted

Precision depth control

E

Effortless

Streamlined workflow

P

Personalized

Patient-specific parameters

We build markets. We don't move units.

What We Need

Looking For

  • KOL relationships and academic channels
  • Dedicated clinical training team
  • Engineering team for post-sales service
  • Academic-first market development
  • Long-term, multi-year orientation
What We Provide

What You Get

  • Comprehensive clinical training
  • Full market materials and brand assets
  • North American KOL network access
  • Sales support framework

Internal
Reports

Strategy briefings and leadership documents. Restricted access.

Get In Touch

We review every inquiry personally. Send a brief introduction: your market, your team, your current line.